Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: July 09, 2026
Fear of Cancer Recurrence in Hematopoietic Cell Transplantation Survivors.
Journal: Transplantation and cellular therapy
Published: January 14, 2026
Autologous and allogeneic hematopoietic cell transplantation in children and adults with high-risk anaplastic large cell lymphoma.
Journal: Frontiers in oncology
Published: January 11, 2026
PTCy or ATG for Matched Transplantation in Myelofibrosis.
Journal: American journal of hematology
Published: January 03, 2026
Pulmonary Complications Following Hematopoietic Cell Transplantation in Patients with Myelofibrosis: A Single-Center Retrospective Cohort Analysis.
Journal: Transplantation and cellular therapy
Published: August 12, 2025
Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective Study.
Journal: Transplantation and cellular therapy
Published: July 21, 2025
Role of molecular alterations in transplantation decisions for patients with primary myelofibrosis.
Journal: Blood advances
Published: July 29, 2024
Barriers and facilitators to routine revaccination among adult Hematopoietic Cell Transplant survivors in the United States: A convergent mixed methods analysis.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: July 25, 2024
NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 11, 2024
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation.
Journal: Bone marrow transplantation
Published: February 14, 2024
Last Updated: 09/26/2026